IDA & IBRD total vs Korea: Immunization, Hib3
IDA & IBRD total
75.9%
in 2024
Korea
97.0%
in 2024
IDA & IBRD total rank
28th
Korea rank
29th
Immunization, Hib3 over time
- IDA & IBRD total
- Korea
How they compare
Korea currently reports 97.0% against 75.9% in IDA & IBRD total, a difference of 21.1%.
That makes Korea's figure about 1.3 times IDA & IBRD total's.
Across all 11 years both countries report, Korea has been ahead every year.
IDA & IBRD total ranks 28th and Korea ranks 29th of 43 groups.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | IDA & IBRD total | Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64.4% | 97.5% | 33.1% | Korea |
| 2020s | 72.6% | 96.6% | 24.0% | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, IDA & IBRD total or Korea?
- Korea, at 97.0% against 75.9% in IDA & IBRD total as of 2024.
- What is the difference in immunization, hib3 between IDA & IBRD total and Korea?
- 21.1%, with Korea ahead.
- How many years of comparable data are there for IDA & IBRD total and Korea?
- 11 years are reported by both, from 2014 to 2024.
- How do IDA & IBRD total and Korea rank globally for immunization, hib3?
- IDA & IBRD total ranks 28th and Korea ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.